PubMed Health⌕ Search

PubMed · 12828519

Adhesive small bowel obstruction: temporary evolution and derived practical consequences.

Abstract

OBJECTIVE: a study is made of the course of adhesive small bowel obstruction in an attempt to draw conclusions regarding useful measures for reducing its incidence and severity. PATIENTS AND METHOD: a retrospective study is made of 146 cases of adhesive small bowel obstruction from the last adhesion-related hospital admission of each patient, with an evaluation of Kaplan-Meier survival curve fit to the principal parametric distributions of the disorder. RESULTS: surgery of the appendix was the type of prior surgery most frequently associated with adhesion occlusion. The mean latency was close to 8 years, with a constant incidence rate of 0.128 cases/patient and year. The initial latency was shorter for colorectal surgery and for prior inframesocolic surgery in general, as well as for conditions of relapse. A prospective follow-up comprising most of the cases (i.e., 95%) could require over 20 years, or up to 10 years to assess the corresponding relapses. CONCLUSIONS: from the clinical research perspective, the best approach to the problem of adhesive small bowel obstruction comprises the evaluation of prophylactic measures against adhesion formation. The more reliable methodological design of investigational studies must be sustained by prospective follow-up supported by hospital admission databases.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

V J Escrig Sos, V Angel Yepes, V Senent Vizcaíno. 2003. Adhesive small bowel obstruction: temporary evolution and derived practical consequences.. https://pubmed.ncbi.nlm.nih.gov/12828519/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Complex partial status epilepticus associated with anti-Hu paraneoplastic syndrome.

Although seizures can be a manifestation of paraneoplastic disorders, there are few descriptions of the association between the anti-Hu paraneoplastic syndrome and epilepsia partialis continua. A new case of refractory complex partial status epilepticus in a patient with a paraneoplastic syndrome associated with a poorly differentiated mediastinal tumor that expressed Hu antigen is described clinically, pathologically, and electrographically. We discuss the presentation of focal seizures in a disease that is characterized by diffuse pathologic involvement of the brain. The progression of EEG, MRI, and clinical findings during the course of the illness is also discussed. To our knowledge, this is the first description of paraneoplastic epilepsia partialis continua associated with diffuse pathologic abnormalities.

Disease Progression↗

Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection.

The natural outcome and response to treatment in hepatitis C virus (HCV) infection varies between individuals. Whereas some variation may be attributable to viral and environmental variables, it is probable that host genetic background also plays a significant role. Interleukin (IL)-10 has a key function in the regulation of cellular immune responses and in the suppression of pro-inflammatory cytokine secretion. Functional polymorphisms in the IL-10 gene have been described. We investigated the role of these polymorphisms in the outcome of HCV infection, treatment response and development of fibrosis in a case-control association study. Self-limiting infection was associated with the IL-10 (-592) AA genotype (OR=2.05; P=0.028). Persistent infection was associated with the IL-10 (-1082) GG genotype (OR=0.48; P=0.018). Sustained response to interferon therapy was associated with the IL-10 (-1082) GG genotype (OR=2.28; P=0.005) and the haplotype GCC (OR=2.27; P=0.020). The IL-10 (-1082) AA genotype and the ATA/ATA and ACC/ACC homozygous haplotypes were more frequent among patients with rapid fibrosis. Furthermore, the microsatellites IL-10.R and IL-10.G were associated with interferon response with IL-10R.2 conveying susceptibility (OR=1.80; P=0.034), and IL-10R.3 and IL-10.G13 being protective (OR=0.47; P=0.003 and OR=0.59; P=0.042, respectively). We conclude that polymorphisms in the IL-10 promoter appear to have some influence on the outcome of HCV infection, treatment and development of fibrosis.

Disease Progression↗